SP08 | FEASIBILITY OF FIXED-DURATION IBRUTINIB PLUS VENETOCLAX COMBINATION AS TREATMENT IN A VERY FRAIL, COMORBID AND BEDRIDDEN PATIENT WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Introduction: Chronic Lymphocytic Leukemia (CLL) accounts for ~1–1.5% of all malignancies and is the most common adult leukemia in Europe and North America. It shows considerable heterogeneity in outcomes, with 50–70% of patients requiring treatment during the disease course. Standard therapies inc...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ferrata Storti Foundation
2025-09-01
|
| coleção: | Haematologica |
| Acesso em linha: | https://haematologica.org/article/view/12328 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|